Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2014C016 Product name: OLODATEROL, sous forme des isomères optiques ou de mélanges d'énantiomères, sous forme de ses sels d'addition d'acide avec des acides pharmaceutiquement acceptables, ou sous forme des solvates et/ou d'hydrates,....

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2014C/016
Type:
Certificate
SPC type:
Medical
Basic patent number:
037783123
Status:
Active
Publication number:
2014C016
1rst applicant's nationality:
Procedural language:
French

Marketing authorization

1

Marketing authorization number:
BE443791
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
23/10/2013
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

2

Marketing authorization number:
MA211/00401
Marketing authorization type:
EEA
Designates country:
No
Marketing authorization date:
18/09/2013
Marketing authorization status:
Accepted
Marketing authorization country:
Malta (MT)

Dates

Filing date:
27/02/2014
First marketing authorization date:
18/09/2013
Grant date:
07/03/2023
Activation date:
11/11/2023
BE Publication date:
25/04/2017
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
17/09/2028
SPC/SPC Extension Expiration (if granted and all annual fees paid):
17/09/2028
Rejection date:
Withdrawal date:

Applicant

Name:
Boehringer Ingelheim Pharma GmbH & Co.KG
Legal Form:
From:
27/02/2014
Address:
Binger Strasse 173, 55216, Ingelheim am Rhein, Germany (DE)
To:

Agent

1

Name:
KIRKPATRICK
Legal Form:
S.A.
From:
23/12/2020
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:

2

Name:
PLUCKER Guy
Legal Form:
From:
27/02/2014
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:
23/12/2020

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2023/21
Publication date:
30/11/2023
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
SPC
Journal edition number:
2023/05
Publication date:
29/03/2023
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

Annual fee

Annual fee(s) Due Date:
01/12/2025
Annual fee number:
23
Annual fee amount:
750 Euro
Expected payer:
Last annual fee payment date:
20/11/2024
Last annual fee paid number:
22
Last annual fee paid amount:
700 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
25/04/2017 Publication I1 1 PDF /6/1/0/4/1/0300014016/docs/2014c016_0_i1document_20170425_102423558.pdf
03/04/2017 General Document Other 6 PDF /6/1/0/4/1/0300014016/docs/2014c016_1_generaldocument_20170425_101821735.pdf
13/03/2023 Request For Change Letter and/or Form requesting a change in the Register 1 PDF /6/1/0/4/1/0300014016/docs/2014c016_2_rfc_20230406_120158427.pdf
07/03/2023 Publication I2 1 PDF /6/1/0/4/1/0300014016/docs/2014c016_3_i2document_20230307_095932867.pdf
07/03/2023 Outgoing Correspondence 2 PDF /6/1/0/4/1/0300014016/docs/2014c016_4_outgoingcorrespondence_20230411_101604818.pdf